Pharmaron Beijing Co Ltd (300759) — Free Cash Flow Generation Index
Pharmaron Beijing Co Ltd (300759) has a Free Cash Flow Generation Index of 0.28x as of September 2025. Free cash flow of CN¥290.95 Million represents 0% of operating cash flow (CN¥1.04 Billion). Read how much debt does Pharmaron Beijing Co Ltd carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Pharmaron Beijing Co Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Pharmaron Beijing Co Ltd across 11 annual periods. Explore 300759 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Pharmaron Beijing Co Ltd. For the full company profile including market capitalisation, see 300759 market cap overview.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | CN¥536.02 Million | CN¥2.58 Billion | CN¥2.04 Billion | ▲ +612.4% |
| 2023 | -0.04x | CN¥-111.78 Million | CN¥2.75 Billion | CN¥2.87 Billion | ▲ +89.2% |
| 2022 | -0.38x | CN¥-807.04 Million | CN¥2.14 Billion | CN¥2.95 Billion | ▼ -2128.8% |
| 2021 | -0.02x | CN¥-34.78 Million | CN¥2.06 Billion | CN¥2.09 Billion | ▼ -108.4% |
| 2020 | 0.20x | CN¥332.77 Million | CN¥1.65 Billion | CN¥1.32 Billion | ▲ +3.0% |
| 2019 | 0.20x | CN¥183.98 Million | CN¥938.59 Million | CN¥754.61 Million | ▲ +50.1% |
| 2018 | 0.13x | CN¥96.27 Million | CN¥737.26 Million | CN¥640.99 Million | ▲ +118.9% |
| 2017 | -0.69x | CN¥-382.45 Million | CN¥552.22 Million | CN¥934.67 Million | ▲ +80.1% |
| 2016 | -3.48x | CN¥-819.72 Million | CN¥235.77 Million | CN¥1.06 Billion | ▼ -1722.6% |
| 2015 | -0.19x | CN¥-41.38 Million | CN¥216.94 Million | CN¥258.32 Million | ▲ +96.7% |
| 2014 | -5.75x | CN¥-69.80 Million | CN¥12.13 Million | CN¥81.94 Million | — |